Correction: Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma

Detalles Bibliográficos
Autores principales: Ruan, Hailong, Li, Sen, Bao, Lin, Zhang, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816057/
https://www.ncbi.nlm.nih.gov/pubmed/36450864
http://dx.doi.org/10.1038/s41388-022-02534-0
_version_ 1784864443810709504
author Ruan, Hailong
Li, Sen
Bao, Lin
Zhang, Xiaoping
author_facet Ruan, Hailong
Li, Sen
Bao, Lin
Zhang, Xiaoping
author_sort Ruan, Hailong
collection PubMed
description
format Online
Article
Text
id pubmed-9816057
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-98160572023-01-07 Correction: Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma Ruan, Hailong Li, Sen Bao, Lin Zhang, Xiaoping Oncogene Correction Nature Publishing Group UK 2022-11-30 2023 /pmc/articles/PMC9816057/ /pubmed/36450864 http://dx.doi.org/10.1038/s41388-022-02534-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Ruan, Hailong
Li, Sen
Bao, Lin
Zhang, Xiaoping
Correction: Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma
title Correction: Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma
title_full Correction: Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma
title_fullStr Correction: Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma
title_full_unstemmed Correction: Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma
title_short Correction: Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma
title_sort correction: enhanced yb1/epha2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816057/
https://www.ncbi.nlm.nih.gov/pubmed/36450864
http://dx.doi.org/10.1038/s41388-022-02534-0
work_keys_str_mv AT ruanhailong correctionenhancedyb1epha2axissignalingpromotesacquiredresistancetosunitinibandmetastaticpotentialinrenalcellcarcinoma
AT lisen correctionenhancedyb1epha2axissignalingpromotesacquiredresistancetosunitinibandmetastaticpotentialinrenalcellcarcinoma
AT baolin correctionenhancedyb1epha2axissignalingpromotesacquiredresistancetosunitinibandmetastaticpotentialinrenalcellcarcinoma
AT zhangxiaoping correctionenhancedyb1epha2axissignalingpromotesacquiredresistancetosunitinibandmetastaticpotentialinrenalcellcarcinoma

Ejemplares similares